Together, these findings indicate that the active phases of IBD patients are marked by the presence of various subsets of effector CD4+ T cells, which can secrete a vast array of cytokines and chemokines, thus contributing to expanding the mucosal immune response. This evidence concerns the gene CD4 and inflammatory bowel disease.